| For: | Cid-Arregui A, Juarez V. Perspectives in the treatment of pancreatic adenocarcinoma. World J Gastroenterol 2015; 21(31): 9297-9316 [PMID: 26309356 DOI: 10.3748/wjg.v21.i31.9297] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i31/9297.htm |
| Number | Citing Articles |
| 1 |
. 2020; doi: 10.70675/05815fd1z5314z4734z8240zd1a40c5a9bdf
|
| 2 |
Fang Xie, Mei Huang, Xiansheng Lin, Chenhai Liu, Zhen Liu, Futao Meng, Chao Wang, Qiang Huang. RETRACTED ARTICLE: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-26496-0
|
| 3 |
Pancreatic Cancer: Basic Mechanisms and Therapies. Advances in Cancer Research 2023; 159 doi: 10.1016/bs.acr.2023.02.010
|
| 4 |
Cristina Jimenez-Luna, Jose Prados, Raul Ortiz, Consolacion Melguizo, Carolina Torres, Octavio Caba. Current Status of Immunotherapy Treatments for Pancreatic Cancer. Journal of Clinical Gastroenterology 2016; 50(10) doi: 10.1097/MCG.0000000000000623
|
| 5 |
Alejandro Garces-Descovich, Trevor C. Morrison, Kevin Beker, Adrian Jaramillo-Cardoso, A. James Moser, Koenraad J. Mortele. DWI of Pancreatic Ductal Adenocarcinoma: A Pilot Study to Estimate the Correlation With Metastatic Disease Potential and Overall Survival. American Journal of Roentgenology 2019; 212(2) doi: 10.2214/AJR.18.20017
|
| 6 |
. 2023; doi: 10.70675/f881b446z9b1az4d24z89cbz2922c25af06e
|
| 7 |
Akihiro Tamaki, Takuya Kato, Yasutaka Sakurai, Keita Sato, Kai Adachi, Masayoshi Tadehara, Taro Kogami, Masahiro Matsushita, Akiyoshi Hoshino, Itaru Sanoyama, Yoshiko Numata, Atsuko Umezawa, Masaaki Ichinoe, Masatoshi Ichihara, Chika Kusano, Yoshiki Murakumo. REV7 is involved in outcomes of platinum‐based chemotherapy in pancreatic cancer by controlling the DNA damage response. Cancer Science 2024; 115(2) doi: 10.1111/cas.16044
|
| 8 |
Aneta Sevcikova, Nikola Izoldova, Viola Stevurkova, Barbora Kasperova, Michal Chovanec, Sona Ciernikova, Michal Mego. The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy. International Journal of Molecular Sciences 2022; 23(1) doi: 10.3390/ijms23010488
|
| 9 |
Kazunori Yoh, Hiroki Nishikawa, Hirayuki Enomoto, Noriko Ishii, Yoshinori Iwata, Akio Ishii, Yukihisa Yuri, Yuho Miyamoto, Kunihiro Hasegawa, Chikage Nakano, Ryo Takata, Takashi Nishimura, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Tomoyuki Takashima, Hiroko Iijima, Shuhei Nishiguchi. Implication of exercise interventions on sleep disturbance in patients with pancreatic cancer: a study protocol for a randomised controlled trial. BMJ Open Gastroenterology 2018; 5(1) doi: 10.1136/bmjgast-2017-000196
|
| 10 |
Weibin Wang, Taiping Zhang, Wenjing Zhao, Lai Xu, Yu Yang, Quan Liao, Yupei Zhao. A Single Talent Immunogenic Membrane Antigen and Novel Prognostic Predictor: voltage-dependent anion channel 1 (VDAC1) in Pancreatic Cancer. Scientific Reports 2016; 6(1) doi: 10.1038/srep33648
|
| 11 |
Rosalinda Trovato, Alessandra Fiore, Sara Sartori, Stefania Canè, Rosalba Giugno, Luciano Cascione, Salvatore Paiella, Roberto Salvia, Francesco De Sanctis, Ornella Poffe, Cristina Anselmi, Francesca Hofer, Silvia Sartoris, Geny Piro, Carmine Carbone, Vincenzo Corbo, Rita Lawlor, Samantha Solito, Laura Pinton, Susanna Mandruzzato, Claudio Bassi, Aldo Scarpa, Vincenzo Bronte, Stefano Ugel. Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3. Journal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0734-6
|
| 12 |
Chih-Wei Lin, Yu-Jen Wang, Ting-Yen Lai, Tsui-Ling Hsu, Shin-Ying Han, Han-Chung Wu, Chia-Ning Shen, Van Dang, Ming-Wei Chen, Lan-Bo Chen, Chi-Huey Wong. Homogeneous antibody and CAR-T cells with improved effector functions targeting SSEA-4 glycan on pancreatic cancer. Proceedings of the National Academy of Sciences 2021; 118(50) doi: 10.1073/pnas.2114774118
|
| 13 |
Kyoichi Harada, Yasutoshi Murayama, Hidemasa Kubo, Hisataka Matsuo, Ryo Morimura, Hisashi Ikoma, Hitoshi Fujiwara, Kazuma Okamoto, Tohru Tanaka, Eigo Otsuji. Photodynamic diagnosis of peritoneal metastasis in human pancreatic cancer using 5‑aminolevulinic acid during staging laparoscopy. Oncology Letters 2018; doi: 10.3892/ol.2018.8732
|
| 14 |
Anne-Laure Bulin, Mans Broekgaarden, Diane Simeone, Tayyaba Hasan. Low dose photodynamic therapy harmonizes with radiation therapy to induce beneficial effects on pancreatic heterocellular spheroids. Oncotarget 2019; 10(27) doi: 10.18632/oncotarget.26780
|
| 15 |
Fotini Poyia, Christiana M. Neophytou, Maria-Ioanna Christodoulou, Panagiotis Papageorgis. The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives. International Journal of Molecular Sciences 2024; 25(17) doi: 10.3390/ijms25179555
|
| 16 |
Jeremy Sharib, Laura Esserman, Eugene J. Koay, Anirban Maitra, Yu Shen, Kimberly S. Kirkwood, Elissa M. Ozanne. Cost-effectiveness of consensus guideline based management of pancreatic cysts: The sensitivity and specificity required for guidelines to be cost-effective. Surgery 2020; 168(4) doi: 10.1016/j.surg.2020.04.052
|
| 17 |
Maria Cristina Curia, Fabiana Fantini, Rossano Lattanzio, Francesca Tavano, Francesco Di Mola, Mauro Piantelli, Pasquale Battista, Pierluigi Di Sebastiano, Alessandro Cama. High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5616-2
|
| 18 |
Dietrich A. Ruess, Kivanc Görgülü, Sonja M. Wörmann, Hana Algül. Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts. Drugs & Aging 2017; 34(5) doi: 10.1007/s40266-017-0453-y
|
| 19 |
Guanhua Lu, Ziyu Han, Min Hu. Optical imaging technology realizes early tumor diagnosis by detecting angiogenesis. Microscopy Research and Technique 2023; 86(2) doi: 10.1002/jemt.24262
|
| 20 |
Yusuke Ogitani, Tetsuo Aida, Katsunobu Hagihara, Junko Yamaguchi, Chiaki Ishii, Naoya Harada, Masako Soma, Hiromi Okamoto, Masataka Oitate, Shingo Arakawa, Takehiro Hirai, Ryo Atsumi, Takashi Nakada, Ichiro Hayakawa, Yuki Abe, Toshinori Agatsuma. DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1. Clinical Cancer Research 2016; 22(20) doi: 10.1158/1078-0432.CCR-15-2822
|
| 21 |
Samira Aghlara-Fotovat, Amanda Nash, Boram Kim, Robert Krencik, Omid Veiseh. Targeting the extracellular matrix for immunomodulation: applications in drug delivery and cell therapies. Drug Delivery and Translational Research 2021; 11(6) doi: 10.1007/s13346-021-01018-0
|
| 22 |
Ayesha Manzur, Adeolu Oluwasanmi, Darren Moss, Anthony Curtis, Clare Hoskins. Nanotechnologies in Pancreatic Cancer Therapy. Pharmaceutics 2017; 9(4) doi: 10.3390/pharmaceutics9040039
|
| 23 |
Michal Bassani-Sternberg, Antonia Digklia, Florian Huber, Dorothea Wagner, Christine Sempoux, Brian J. Stevenson, Anne-Christine Thierry, Justine Michaux, HuiSong Pak, Julien Racle, Caroline Boudousquie, Klara Balint, George Coukos, David Gfeller, Silvia Martin Lluesma, Alexandre Harari, Nicolas Demartines, Lana E. Kandalaft. A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma—A Proof of Antigen Discovery Feasibility in Three Patients. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.01832
|
| 24 |
Jeffery Ho, Xianchun Li, Lin Zhang, Yonghao Liang, Wei Hu, Johnny C.W. Yau, Hung Chan, Tony Gin, Matthew T.V. Chan, Gary Tse, William K.K. Wu. Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset. Seminars in Cancer Biology 2019; 55 doi: 10.1016/j.semcancer.2018.04.004
|
| 25 |
Victor O. Oria, Paul Lopatta, Tatjana Schmitz, Bogdan‐Tiberius Preca, Alexander Nyström, Catharina Conrad, Jörg W. Bartsch, Birte Kulemann, Jens Hoeppner, Jochen Maurer, Peter Bronsert, Oliver Schilling. ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma. Molecular Oncology 2019; 13(2) doi: 10.1002/1878-0261.12426
|
| 26 |
Mihir M. Shah, Jashodeep Datta, Nipun B. Merchant, David A. Kooby. Landmark Series: Importance of Pancreatic Resection Margins. Annals of Surgical Oncology 2022; 29(3) doi: 10.1245/s10434-021-11168-7
|
| 27 |
Susan S. Butler, Kenjiro Date, Takashi Okumura, Cooper Lueck, Bidyut Ghosh, Anirban Maitra, Junghae Suh. Membrane-bound MMP-14 protease-activatable adeno-associated viral vectors for gene delivery to pancreatic tumors. Gene Therapy 2022; 29(3-4) doi: 10.1038/s41434-021-00255-9
|
| 28 |
Aslam Syed, Olivia Babich, Bharat Rao, Shailendra Singh, Neil Carleton, Abhishek Gulati, Archana Kulkarni, Mrinal Garg, Katie Farah, Gursimran Kochhar, Suzanne Morrissey, Marcia Mitre, Abhijit Kulkarni, Manish Dhawan, Jan F. Silverman, Majed Pharaon, Shyam Thakkar. Endoscopic ultrasound guided fine‐needle aspiration vs core needle biopsy for solid pancreatic lesions: Comparison of diagnostic accuracy and procedural efficiency. Diagnostic Cytopathology 2019; 47(11) doi: 10.1002/dc.24277
|
| 29 |
Thomas J. Ettrich, Lukas Perkhofer, Goetz von Wichert, Thomas M. Gress, Patrick Michl, Holger F. Hebart, Petra Büchner-Steudel, Michael Geissler, Rainer Muche, Bettina Danner, Volker Kächele, Andreas W. Berger, Melanie Güthle, Thomas Seufferlein. DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2052-4
|
| 30 |
Nicola Silvestris, Oronzo Brunetti, Enrico Vasile, Francesco Cellini, Ivana Cataldo, Valeria Pusceddu, Monica Cattaneo, Stefano Partelli, Mario Scartozzi, Giuseppe Aprile, Andrea Casadei Gardini, Alessio Giuseppe Morganti, Vincenzo Valentini, Aldo Scarpa, Massimo Falconi, Angela Calabrese, Vito Lorusso, Michele Reni, Stefano Cascinu. Multimodal treatment of resectable pancreatic ductal adenocarcinoma. Critical Reviews in Oncology/Hematology 2017; 111 doi: 10.1016/j.critrevonc.2017.01.015
|
| 31 |
Wenbing Dai, Xiaoyou Wang, Ge Song, Tongzhou Liu, Bing He, Hua Zhang, Xueqing Wang, Qiang Zhang. Combination antitumor therapy with targeted dual-nanomedicines. Advanced Drug Delivery Reviews 2017; 115 doi: 10.1016/j.addr.2017.03.001
|
| 32 |
Ralph H Hruban, Matthias M Gaida, Elizabeth Thompson, Seung‐Mo Hong, Michaël Noë, Lodewijk AA Brosens, Martine Jongepier, G Johan A Offerhaus, Laura D Wood. Why is pancreatic cancer so deadly? The pathologist's view. The Journal of Pathology 2019; 248(2) doi: 10.1002/path.5260
|
| 33 |
Michelle K. Greene, Michael C. Johnston, Christopher J. Scott. Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance. Cancers 2021; 13(24) doi: 10.3390/cancers13246175
|
| 34 |
Jacqueline Jones, Angana Mukherjee, Balasubramanyam Karanam, Melissa Davis, Jesse Jaynes, R. Renee Reams, Windy Dean-Colomb, Clayton Yates. African Americans with pancreatic ductal adenocarcinoma exhibit gender differences in Kaiso expression. Cancer Letters 2016; 380(2) doi: 10.1016/j.canlet.2016.06.025
|
| 35 |
Janaiah Kota, Julie Hancock, Jason Kwon, Murray Korc. Pancreatic cancer: Stroma and its current and emerging targeted therapies. Cancer Letters 2017; 391 doi: 10.1016/j.canlet.2016.12.035
|
| 36 |
Kentaro Ozaki, Hiromitsu Hayashi, Yoshiaki Ikuta, Toshiro Masuda, Shinichi Akaboshi, Kenichi Ogata, Katsutaka Matumoto, Katsuhiro Ogawa, Takihiro Kamio, Hideo Baba, Hiroshi Takamori. Conversion surgery for initially unresectable pancreatic ductal adenocarcinoma with synchronous liver metastasis after treatment with FOLFIRINOX. Clinical Journal of Gastroenterology 2019; 12(6) doi: 10.1007/s12328-019-00965-z
|
| 37 |
Xueqing Chen, Wei Rao, Yi Shi, Jing Liu. Minimally Invasive Injectable Thermochemical Ablation Therapy of Malignant Tumor via Alkali Metal Fluid. Biomedical Materials & Devices 2023; 1(1) doi: 10.1007/s44174-022-00016-1
|
| 38 |
Weibin Wang, Lai Xu, Yu Yang, LiangBo Dong, BangBo Zhao, Jun Lu, Taiping Zhang, Yupei Zhao. A novel prognostic marker and immunogenic membrane antigen: prohibitin (PHB) in pancreatic cancer. Clinical and Translational Gastroenterology 2018; 9(9) doi: 10.1038/s41424-018-0044-1
|
| 39 |
Concetta Panebianco, Kaarel Adamberg, Signe Adamberg, Chiara Saracino, Madis Jaagura, Kaia Kolk, Anna Di Chio, Paolo Graziano, Raivo Vilu, Valerio Pazienza. Engineered Resistant-Starch (ERS) Diet Shapes Colon Microbiota Profile in Parallel with the Retardation of Tumor Growth in In Vitro and In Vivo Pancreatic Cancer Models. Nutrients 2017; 9(4) doi: 10.3390/nu9040331
|
| 40 |
Xiucong Pei, Jianhui Zhu, Rui Yang, Zhijing Tan, Mingrui An, Jiaqi Shi, David M. Lubman, Pankaj K Singh. CD90 and CD24 Co-Expression Is Associated with Pancreatic Intraepithelial Neoplasias. PLOS ONE 2016; 11(6) doi: 10.1371/journal.pone.0158021
|
| 41 |
Tainara F. Felix, Rainer M. Lopez Lapa, Márcio de Carvalho, Natália Bertoni, Tomas Tokar, Rogério A. Oliveira, Maria A. M. Rodrigues, Cláudia N. Hasimoto, Walmar K. Oliveira, Leonardo Pelafsky, César T. Spadella, Juan C. Llanos, Giovanni F. Silva, Wan L. Lam, Silvia Regina Rogatto, Luciana Schultz Amorim, Sandra A. Drigo, Robson F. Carvalho, Patricia P. Reis, Surinder K. Batra. MicroRNA modulated networks of adaptive and innate immune response in pancreatic ductal adenocarcinoma. PLOS ONE 2019; 14(5) doi: 10.1371/journal.pone.0217421
|
| 42 |
Hye Yeon Yang, Jae Uk Chong, Mi Jang, Sung Hwan Lee, Ho Kyoung Hwang, Woo Jung Lee, Chang Moo Kang. Stromal secreted protein acidic and rich in cysteine expression: A potential target for improved prognosis in patients with pancreatic cancer. World Journal of Gastrointestinal Oncology 2025; 17(11): 110704 doi: 10.4251/wjgo.v17.i11.110704
Abstract(138) |
Core Tip(125) |
Full Article(HTML)(432)
|
Full Article (PDF)-16157K(81)
|
Full Article with Cover (PDF)-16468K(75)
|
Full Article (XML)-198K(55)
|
Audio-1436K(13)
|
Peer-Review Report-267K(52)
|
Answering Reviewers-1035K(70)
|
Supplementary Material-338K(53)
|
Times Cited (0)
|
Total Visits (830)
|
Open
|
| 43 |
Jashodeep Datta, Brent A. Willobee, Emily L. Ryon, Mihir M. Shah, Jeffrey A. Drebin, David A. Kooby, Nipun B. Merchant. Contemporary Reappraisal of Intraoperative Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma. JAMA Surgery 2021; 156(5) doi: 10.1001/jamasurg.2020.5676
|
| 44 |
P. G. Tarazov, A. V. Kozlov, D. A. Granov, A. V. Pavlovskiy, A. A. Polikarpov, E. V. Rozengaus, S. A. Popov, E. V. Vlasova, V. E. Moiseenko. ARTERIAL CHEMOINFUSION IN PATIENTS WITH LOCALLY ADVANCED AND METASTATIC PANCREAS CANCER. Grekov's Bulletin of Surgery 2016; 175(5) doi: 10.24884/0042-4625-2016-175-5-36-40
|
| 45 |
Magdalena Misiura, Justyna Zińczuk, Konrad Zaręba, Dorota Kamińska, Katarzyna Guzińska-Ustymowicz, Anna Pryczynicz. Actin-Bundling Proteins (Actinin-4 and Fascin-1) are Involved in the Development of Pancreatic Intraepithelial Neoplasia (PanIN). The American Journal of the Medical Sciences 2020; 359(3) doi: 10.1016/j.amjms.2019.11.013
|
| 46 |
Minoru Tomizawa, Fuminobu Shinozaki, Yoshitaka Uchida, Katsuhiro Uchiyama, Satomi Tanaka, Takafumi Sunaoshi, Daisuke Kano, Eriko Sugiyama, Misaki Shite, Ryouta Haga, Yoshiya Fukamizu, Toshiyuki Fujita, Satoshi Kagayama, Rumiko Hasegawa, Yoshinori Shirai, Yasufumi Motoyoshi, Takao Sugiyama, Shigenori Yamamoto, Naoki Ishige. Comparison of DWIBS/T2 image fusion and PET/CT for the diagnosis of cancer in the abdominal cavity. Experimental and Therapeutic Medicine 2017; 14(4) doi: 10.3892/etm.2017.4987
|
| 47 |
Nisebita Sahu, Emily Chan, Felix Chu, Thinh Pham, Hartmut Koeppen, William Forrest, Mark Merchant, Jeff Settleman. Cotargeting of MEK and PDGFR/STAT3 Pathways to Treat Pancreatic Ductal Adenocarcinoma. Molecular Cancer Therapeutics 2017; 16(9) doi: 10.1158/1535-7163.MCT-17-0009
|
| 48 |
Kang Hyun Kim, Ho Kyoung Hwang, In Cheon Kang, Woo Jung Lee, Chang Moo Kang. Oncologic impact of preoperative prognostic nutritional index change in resected pancreatic cancer following neoadjuvant chemotherapy. Pancreatology 2020; 20(2) doi: 10.1016/j.pan.2019.12.006
|
| 49 |
R. Araujo-Gutierrez, J. L. Van Eps, D. Kirui, N. S. Bryan, Y. Kang, J. B. Fleming, J. S. Fernandez-Moure. Enhancement of gemcitabine cytotoxicity in pancreatic adenocarcinoma through controlled release of nitric oxide. Biomedical Microdevices 2019; 21(1) doi: 10.1007/s10544-019-0375-z
|
| 50 |
. 2017; doi: 10.70675/5c2d9beaz74c5z4a71z80b0zabce84fcefbc
|
| 51 |
Kanan Panchal, Rakesh Kumar Sahoo, Umesh Gupta, Akash Chaurasiya. Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview. International Immunopharmacology 2021; 95 doi: 10.1016/j.intimp.2021.107508
|
| 52 |
Hexige Saiyin, Ning Na, Xu Han, Yuan Fang, Yanhua Wu, Wenhui Lou, Xianmei Yang. BRSK2 induced by nutrient deprivation promotes Akt activity in pancreatic cancer via downregulation of mTOR activity. Oncotarget 2017; 8(27) doi: 10.18632/oncotarget.17965
|
| 53 |
Chenxi Tian, Daniel Öhlund, Steffen Rickelt, Tommy Lidström, Ying Huang, Liangliang Hao, Renee T. Zhao, Oskar Franklin, Sangeeta N. Bhatia, David A. Tuveson, Richard O. Hynes. Cancer Cell–Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma. Cancer Research 2020; 80(7) doi: 10.1158/0008-5472.CAN-19-2578
|
| 54 |
Concetta Panebianco, Kaarel Adamberg, Madis Jaagura, Massimiliano Copetti, Andrea Fontana, Signe Adamberg, Kaia Kolk, Raivo Vilu, Angelo Andriulli, Valerio Pazienza. Influence of gemcitabine chemotherapy on the microbiota of pancreatic cancer xenografted mice. Cancer Chemotherapy and Pharmacology 2018; 81(4) doi: 10.1007/s00280-018-3549-0
|
| 55 |
Faliang Xing, Qiangsheng Hu, Yi Qin, Jin Xu, Bo Zhang, Xianjun Yu, Wei Wang. The Relationship of Redox With Hallmarks of Cancer: The Importance of Homeostasis and Context. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.862743
|
| 56 |
Michael J. Wright, Heidi N. Overton, Jonathan A. Teinor, Ding Ding, Richard A. Burkhart, John L. Cameron, Jin He, Christopher L. Wolfgang, Matthew J. Weiss, Ammar A. Javed. Disparities in the Use of Chemotherapy in Patients with Resected Pancreatic Ductal Adenocarcinoma. Journal of Gastrointestinal Surgery 2020; 24(7) doi: 10.1007/s11605-019-04311-z
|
| 57 |
Ayşe Ufuk, Terence Garner, Adam Stevens, Ayşe Latif. Monocarboxylate Transporters Are Involved in Extracellular Matrix Remodelling in Pancreatic Ductal Adenocarcinoma. Cancers 2022; 14(5) doi: 10.3390/cancers14051298
|
| 58 |
Antonella Muscella, Luca G. Cossa, Erika Stefàno, Gianluca Rovito, Michele Benedetti, Francesco P. Fanizzi, Santo Marsigliante. Different Cytotoxic Effects of Cisplatin on Pancreatic Ductal Adenocarcinoma Cell Lines. International Journal of Molecular Sciences 2024; 25(24) doi: 10.3390/ijms252413662
|
| 59 |
Penelope Edwards, Byung Woog Kang, Ian Chau. Targeting the Stroma in the Management of Pancreatic Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.691185
|
| 60 |
Paola Briseño-Díaz, Michael Schnoor, Martiniano Bello-Ramirez, Jose Correa-Basurto, Arturo Rojo-Domínguez, Leticia Arregui, Libia Vega, Enrique Núñez-González, Luis Andres Palau-Hernández, Carlos Guadalupe Parra-Torres, Óscar Manuel García Córdova, Ernesto Zepeda-Castilla, Eduardo Torices-Escalante, Leticia Domínguez-Camacho, Beatriz Xoconostle-Cazares, Marco Antonio Meraz-Ríos, Sandra Delfín-Azuara, Dayan Andrea Carrión-Estrada, Nicolas Villegas-Sepúlveda, Rosaura Hernández-Rivas, Maria del Rocio Thompson-Bonilla, Miguel Vargas. Synergistic effect of antagonists to KRas4B/PDE6 molecular complex in pancreatic cancer. Life Science Alliance 2023; 6(12) doi: 10.26508/lsa.202302019
|
| 61 |
Hsuan-Ju Kuo, Yu-Wen Tien, Nien-Tzu Chang, Yun-Jen Chou, Shiow-Ching Shun. Comparison of Fatigue and Quality of Life in Individuals With Pancreatogenic Diabetes After Total or Partial Pancreatectomy. Oncology Nursing Forum 2019; 46(5) doi: 10.1188/19.ONF.E159-E170
|
| 62 |
Farid G Khalafalla, Mohammad W Khan. Inflammation and Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Fighting Against Multiple Opponents. Cancer Growth and Metastasis 2017; 10 doi: 10.1177/1179064417709287
|
| 63 |
Qianwen Yu, Xian Tang, Wei Zhao, Yue Qiu, Jiao He, Dandan Wan, Jianping Li, Xuhui Wang, Xuan He, Yayuan Liu, Man Li, Zhirong Zhang, Qin He. Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using size-adjustable nanoparticles. Acta Biomaterialia 2021; 133 doi: 10.1016/j.actbio.2021.05.002
|
| 64 |
Kimmie Ng, Andrew Hendifar, Alexander Starodub, Jorge Chaves, Yingsi Yang, Brian Koh, David Barbie, William C. Hahn, Charles S. Fuchs. Phase 1 dose-escalation study of momelotinib, a Janus kinase 1/2 inhibitor, combined with gemcitabine and nab-paclitaxel in patients with previously untreated metastatic pancreatic ductal adenocarcinoma. Investigational New Drugs 2019; 37(1) doi: 10.1007/s10637-018-0650-5
|
| 65 |
Jin-Hui Zhu, Qiu-Liang Yan, Jian-Wei Wang, Yan Chen, Qing-Huang Ye, Zhi-Jiang Wang, Tao Huang. The Key Genes for Perineural Invasion in Pancreatic Ductal Adenocarcinoma Identified With Monte-Carlo Feature Selection Method. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.554502
|
| 66 |
Chenxi Tian, Ying Huang, Karl R. Clauser, Steffen Rickelt, Allison N. Lau, Steven A. Carr, Matthew G. Vander Heiden, Richard O. Hynes. Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cells. Nature Communications 2021; 12(1) doi: 10.1038/s41467-021-22490-9
|
| 67 |
He Cheng, Guopei Luo, Yu Lu, Kaizhou Jin, Meng Guo, Jin Xu, Jiang Long, Liang Liu, Xianjun Yu, Chen Liu. The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients. Pancreatology 2016; 16(6) doi: 10.1016/j.pan.2016.09.007
|
| 68 |
Nikola Knoll, Sarah Masser, Blanka Bordas, Richard Y. Ebright, Guangyan Li, Devishi Kesar, Eliana Destefanis, Nicholas Kania, Diego J. Rodriguez, Jayu Jen, Sydney E. Zagar, Caleb Mensah, Zixin Chen, Samuel J. Moffitt, Erhumuoghene M. Enakireru, Yao He, Baomou Feng, Mira K. Chokshi, Cyrus Y. Jin, Srivatsan Raghavan, William R. Sellers, Kathleen M. Mulvaney. CRISPR–Drug Combinatorial Screening Identifies Effective Combination Treatments for MTAP-Deleted Cancer. Cancer Research 2025; 85(18) doi: 10.1158/0008-5472.CAN-25-1464
|
| 69 |
. 2017; doi: 10.70675/b2ab1c80zb5caz47c4za53bz83c66b494fda
|
| 70 |
Robert Roskoski. Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes. Pharmacological Research 2016; 103 doi: 10.1016/j.phrs.2015.10.021
|
| 71 |
Chandra Diwakarla, Katherine Hannan, Nadine Hein, Desmond Yip. Advanced pancreatic ductal adenocarcinoma - Complexities of treatment and emerging therapeutic options. World Journal of Gastroenterology 2017; 23(13): 2276-2285 doi: 10.3748/wjg.v23.i13.2276
|
| 72 |
Tareq Al Saoudi, Kanika Chawla, Dawud Sarwar, John Isherwood, Neil Bhardwaj, Ashley Dennison, Giuseppe Garcea. PET-CT in initially resectable pancreatic cancer: Does it change the management?. Clinical Surgical Oncology 2026; 5(2) doi: 10.1016/j.cson.2026.100131
|
| 73 |
Abdul Kareem Khan, Akriti Gupta Jain, Summia Afridi, Mohammed Wazir, Jana Srinivas Rao, Sarfraz Ahmad. Theranostic Approach for Pancreatic Cancer. 2019; doi: 10.1016/B978-0-12-819457-7.00006-2
|
| 74 |
Fangjian Li, Zixiang Tang, Yating Zheng, Tao Jiang, Lin Deng, Wenjie Dai, Yuxing Zhao, Nan Zheng, Siman Liu, Yuxuan Fan, Sihan Lu, Yanxi Chen, Gang Liu, Yang Zhang, Yongfu Xiong. Responsive nanomedicine strategies achieve pancreatic cancer precise theranostics. Bioactive Materials 2026; 55 doi: 10.1016/j.bioactmat.2025.08.012
|
| 75 |
Diedron Lewis, Laura Jiménez, Kelvin K. Chan, Susan Horton, William W. L. Wong. A Systematic Review of Cost-Effectiveness Studies on Pancreatic Cancer Screening. Current Oncology 2025; 32(4) doi: 10.3390/curroncol32040225
|
| 76 |
Yu. I. Patyutko, A. G. Kotelnikov, A. N. Polyakov, V. D. Podluzhnyi. Evolution of surgery for pancreatic head and periampullary cancer. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2019; 24(3) doi: 10.16931/1995-5464.2019345-53
|
| 77 |
Kazunori Yoh, Hiroki Nishikawa, Hirayuki Enomoto, Noriko Ishii, Yoshinori Iwata, Akio Ishii, Yukihisa Yuri, Yuho Miyamoto, Kunihiro Hasegawa, Chikage Nakano, Ryo Takata, Takashi Nishimura, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Tomoyuki Takashima, Hiroko Iijima, Shuhei Nishiguchi. Effect of exercise therapy on sarcopenia in pancreatic cancer: a study protocol for a randomised controlled trial. BMJ Open Gastroenterology 2018; 5(1) doi: 10.1136/bmjgast-2017-000194
|
| 78 |
Kangchun Wang, Xin Wang, Qi Pan, Bei Zhao. Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation. Molecular Cancer 2023; 22(1) doi: 10.1186/s12943-023-01870-3
|
| 79 |
Beatrice Dufrusine, Verena Damiani, Emily Capone, Damiana Pieragostino, Enrico Dainese, Margot De Marco, Francesca Reppucci, Maria C. Turco, Alessandra Rosati, Liberato Marzullo, Gianluca Sala, Michele Sallese, Vincenzo De Laurenzi. BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration. Journal of Cellular Biochemistry 2022; 123(1) doi: 10.1002/jcb.30172
|
| 80 |
Jian-wei Xu, Lei Wang, Yu-gang Cheng, Guang-yong Zhang, San-yuan Hu, Bin Zhou, Han-xiang Zhan. Immunotherapy for pancreatic cancer: A long and hopeful journey. Cancer Letters 2018; 425 doi: 10.1016/j.canlet.2018.03.040
|
| 81 |
A. V. Kozlov, P. G. Tarazov. Intra-Arterial Chemotherapy for Pancreatic Cancer. Journal of oncology: diagnostic radiology and radiotherapy 2021; 4(2) doi: 10.37174/2587-7593-2021-4-2-60-68
|
| 82 |
Guettchina Telisnor, David L. DeRemer, Esther Frimpong, Edward Agyare, John Allen, Luisel Ricks-Santi, Bo Han, Thomas George, Sherise C. Rogers. Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans. Journal of the National Medical Association 2023; 115(2) doi: 10.1016/j.jnma.2023.01.008
|
| 83 |
Yufu Wang, Tianyi Fang, Lining Huang, Hao Wang, Lei Zhang, Zhidong Wang, Yunfu Cui. Neutrophils infiltrating pancreatic ductal adenocarcinoma indicate higher malignancy and worse prognosis. Biochemical and Biophysical Research Communications 2018; 501(1) doi: 10.1016/j.bbrc.2018.05.024
|
| 84 |
Xiu Zhang, Dan Wu, Mohanad Aldarouish, Xiaodong Yin, Chunyan Li, Cailian Wang. ETS-1: A potential target of glycolysis for metabolic therapy by regulating glucose metabolism in pancreatic cancer. International Journal of Oncology 2017; 50(1) doi: 10.3892/ijo.2016.3770
|
| 85 |
T.R.J. Evans, E. Van Cutsem, M.J. Moore, I.S. Bazin, A. Rosemurgy, G. Bodoky, G. Deplanque, M. Harrison, B. Melichar, D. Pezet, A. Elekes, E. Rock, C. Lin, L. Strauss, P.J. O’Dwyer. Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancer. Annals of Oncology 2017; 28(2) doi: 10.1093/annonc/mdw607
|
| 86 |
Mark Conor Harris, Georgi Atanasov, Eu Nice Neo, Andrew Goldfinch, Andrew Jin‐Hean Ng, Khimseng Tew, Lilian Kuan, Markus Trochsler, Harsh Kanhere. Value of the surgical pancreatic duct anatomy and associated outcomes in pancreatic cancer. ANZ Journal of Surgery 2024; 94(5) doi: 10.1111/ans.18903
|
| 87 |
Bojan Trogrlić, Zrinka Požgain, Goran Augustin, Borna Kovačić, Dejan Hil, Ivan Šerić, Veronika Šikić. Diagnostic and prognostic values of pancreatic juice carbohydrate antigen 19-9 and carcinoembryonic antigen levels in patients with pancreatic cancer. World Journal of Gastrointestinal Oncology 2026; 18(5): 119610 doi: 10.4251/wjgo.v18.i5.119610
|
| 88 |
Po-Chen Chu, Samuel K. Kulp, Tanios Bekaii-Saab, Ching-Shih Chen. Targeting integrin-linked kinase to suppress oncogenic KRAS signaling in pancreatic cancer. Small GTPases 2018; 9(6) doi: 10.1080/21541248.2016.1251383
|
| 89 |
Eleni Kotsampasakou, Gerhard F. Ecker. Transporters as Drug Targets. Methods and Principles in Medicinal Chemistry 2017; doi: 10.1002/9783527679430.ch12
|
| 90 |
Dhana Sekhar Reddy Bandi, Sujith Sarvesh, Jeremy Foote, Doug Welsch, Changde Cheng, Mehmet Akce, Ganji Purnachandra Nagaraju, Bassel F. El-Rayes. Paricalcitol and hydroxychloroquine modulates extracellular matrix and enhance chemotherapy efficacy in pancreatic cancer. Cancer Gene Therapy 2025; 32(12) doi: 10.1038/s41417-025-00967-9
|
| 91 |
Bahareh Shateri Amiri, Mehrasa Naserranjbar, Fatemeh Aliabadi, Alireza Hejrati, Lina Hejrati. Autophagy: a novel target in order to overcome drug resistance in pancreatic adenocarcinoma. Open Biology 2025; 15(10) doi: 10.1098/rsob.240412
|
| 92 |
Linfeng Yang, Duan Yan, Jun Yu, Dawei Deng, Lin Ma, Ruixin Yu, Song Wei, Jiahui Yu, Chuan Lan, Pengsheng Yi. Prognostic Value of TBC1D1 and Its Relationship With the Tumor Microenvironment in Pancreatic Cancer: A Study Based on Single‐Cell Sequencing. FASEB BioAdvances 2025; 7(7) doi: 10.1096/fba.2025-00092
|
| 93 |
Simone Polvani, Mirko Tarocchi, Sara Tempesti, Lapo Bencini, Andrea Galli. Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer. World Journal of Gastroenterology 2016; 22(8): 2441-2459 doi: 10.3748/wjg.v22.i8.2441
|
| 94 |
A. V. Kozlov, D. A. Granov, P. G. Tarazov, A. V. Pavlovskiy, L. I. Korytova, A. A. Polikarpov, S. A. Popov, E. V. Rozengauz. Intra-arterial chemotherapy for advanced pancreatic cancer. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2019; 24(3) doi: 10.16931/1995-5464.2019373-86
|
| 95 |
Shuang Liu, Yubin Ge, Tingting Wang, Holly Edwards, Qihang Ren, Yiqun Jiang, Chengshi Quan, Guan Wang. Inhibition of ATR potentiates the cytotoxic effect of gemcitabine on pancreatic cancer cells through enhancement of DNA damage and abrogation of ribonucleotide reductase induction by gemcitabine. Oncology Reports 2017; 37(6) doi: 10.3892/or.2017.5580
|
| 96 |
Joy M. Davis, Binglu Cheng, Madeline M. Drake, Qiang Yu, Baibing Yang, Jing Li, Chunhui Liu, Mamoun Younes, Xiurong Zhao, Jennifer M. Bailey, Qiang Shen, Tien C. Ko, Yanna Cao. Pancreatic stromal Gremlin 1 expression during pancreatic tumorigenesis. Genes & Diseases 2022; 9(1) doi: 10.1016/j.gendis.2020.05.001
|
| 97 |
Mozhgan Mondeali, Fatemeh Mozaffari, Pooran Ghiasizadeh, Sanaz Bakhti, Marjan Salehi, Navid Kamali, Milad Rafat. miR-216 Is a Key Regulator and Potential Marker in Human Cancers. Advanced Biomedical Research 2025; 14(1) doi: 10.4103/abr.abr_184_23
|
| 98 |
Marta Serafini, Enza Torre, Silvio Aprile, Erika Del Grosso, Alessandro Gesù, Alessia Griglio, Giorgia Colombo, Cristina Travelli, Salvatore Paiella, Annalisa Adamo, Elena Orecchini, Alice Coletti, Maria Teresa Pallotta, Stefano Ugel, Alberto Massarotti, Tracey Pirali, Silvia Fallarini. Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity. Journal of Medicinal Chemistry 2020; 63(6) doi: 10.1021/acs.jmedchem.9b01809
|
| 99 |
Evan S. Glazer, Omar M. Rashid, Jose M. Pimiento, Pamela J. Hodul, Mokenge P. Malafa. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma. Surgery 2016; 160(5) doi: 10.1016/j.surg.2016.04.039
|
| 100 |
Jonas R.M. Van Audenaerde, Jorrit De Waele, Elly Marcq, Jinthe Van Loenhout, Eva Lion, Johan M.J. Van den Bergh, Ralf Jesenofsky, Atsushi Masamune, Geert Roeyen, Patrick Pauwels, Filip Lardon, Marc Peeters, Evelien L.J. Smits. Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells. Oncotarget 2017; 8(34) doi: 10.18632/oncotarget.18185
|
| 101 |
Pei Fan, Li Liu, Yefeng Yin, Zhefu Zhao, Yiyao Zhang, Prince S. Amponsah, Xi Xiao, Nathalie Bauer, Alia Abukiwan, Clifford C. Nwaeburu, Jury Gladkich, Chao Gao, Peter Schemmer, Wolfgang Gross, Ingrid Herr. MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer. Cancer Letters 2016; 373(1) doi: 10.1016/j.canlet.2016.01.038
|
| 102 |
Carsten H. Nielsen, Troels E. Jeppesen, Lotte K. Kristensen, Mette M. Jensen, Henrik H. El Ali, Jacob Madsen, Bo Wiinberg, Lars C. Petersen, Andreas Kjaer. PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site–Inhibited Factor VII. Journal of Nuclear Medicine 2016; 57(7) doi: 10.2967/jnumed.115.170266
|
| 103 |
Lotfi Abou-Elkacem, Huaijun Wang, Sayan M. Chowdhury, Richard H. Kimura, Sunitha V. Bachawal, Sanjiv S. Gambhir, Lu Tian, Jürgen K. Willmann. Thy1-Targeted Microbubbles for Ultrasound Molecular Imaging of Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research 2018; 24(7) doi: 10.1158/1078-0432.CCR-17-2057
|
| 104 |
Dongge Yin, Hongyue Chen, Xiaohong Jing, Shuting Lin, Yufei Sun, Rongrong Chang, Yang Feng, Xiaoxv Dong, Changhai Qu, Jian Ni, Xingbin Yin. Cucurbitacin B from Cucurbitaceae Plants: Treating Pancreatic Cancer via Inducing Mitophagy, Inhibiting Glycolysis, and Enhancing Immune Function. Nutrients 2025; 17(17) doi: 10.3390/nu17172809
|
| 105 |
Hsiao-Ching Chuang, Po-Hsien Huang, Samuel K. Kulp, Ching-Shih Chen. Pharmacological strategies to target oncogenic KRAS signaling in pancreatic cancer. Pharmacological Research 2017; 117 doi: 10.1016/j.phrs.2017.01.006
|
| 106 |
Nicola Rath, Jennifer P Morton, Linda Julian, Lena Helbig, Shereen Kadir, Ewan J McGhee, Kurt I Anderson, Gabriela Kalna, Margaret Mullin, Andreia V Pinho, Ilse Rooman, Michael S Samuel, Michael F Olson. ROCK signaling promotes collagen remodeling to facilitate invasive pancreatic ductal adenocarcinoma tumor cell growth. EMBO Molecular Medicine 2017; 9(2) doi: 10.15252/emmm.201606743
|
| 107 |
Qiangsheng Hu, Yi Qin, Bo Zhang, Chen Liang, Shunrong Ji, Si Shi, Wenyan Xu, Jinfeng Xiang, Dingkong Liang, Quanxing Ni, Xianjun Yu, Jin Xu. FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1. Oncology Reports 2017; 38(4) doi: 10.3892/or.2017.5856
|
| 108 |
Anita Thyagarajan, Mamdouh Salman A. Alshehri, Kelly L.R. Miller, Catherine M. Sherwin, Jeffrey B. Travers, Ravi P. Sahu. Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches. Cancers 2019; 11(11) doi: 10.3390/cancers11111627
|
| 109 |
Androulla Elia, Ricky Henry-Grant, Charlotte Adiseshiah, Catherine Marboeuf, Rebecca J Buckley, Michael J Clemens, Satvinder Mudan, Stéphane Pyronnet. Implication of 4E-BP1 protein dephosphorylation and accumulation in pancreatic cancer cell death induced by combined gemcitabine and TRAIL. Cell Death & Disease 2017; 8(12) doi: 10.1038/s41419-017-0001-z
|
| 110 |
Sung-Hsin Kuo, Shih-Hung Yang, Ming-Feng Wei, Hsiao-Wei Lee, Yu-Wen Tien, Ann-Lii Cheng, Kun-Huei Yeh. Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signaling. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02143-z
|
| 111 |
Jie Hou, Zhan Wang, Hong Li, Hongzhi Zhang, Lan Luo. Gene Signature and Identification of Clinical Trait-Related m6 A Regulators in Pancreatic Cancer. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00522
|
| 112 |
Varintra E. Lander, Jad I. Belle, Natalie L. Kingston, John M. Herndon, Graham D. Hogg, Xiuting Liu, Liang-I Kang, Brett L. Knolhoff, Savannah J. Bogner, John M. Baer, Chong Zuo, Nicholas C. Borcherding, Daniel P. Lander, Cedric Mpoy, Jalen Scott, Michael Zahner, Buck E. Rogers, Julie K. Schwarz, Hyun Kim, David G. DeNardo. Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade. Cancer Discovery 2022; 12(12) doi: 10.1158/2159-8290.CD-22-0192
|
| 113 |
Samantha T. Tucci, Azadeh Kheirolomoom, Elizabeth S. Ingham, Lisa M. Mahakian, Sarah M. Tam, Josquin Foiret, Neil E. Hubbard, Alexander D. Borowsky, Mo Baikoghli, R. Holland Cheng, Katherine W. Ferrara. Tumor-specific delivery of gemcitabine with activatable liposomes. Journal of Controlled Release 2019; 309 doi: 10.1016/j.jconrel.2019.07.014
|
| 114 |
Zhaoyan Qiu, Yi Chu, Bing Xu, Qian Wang, Mingzuo Jiang, Xiaowei Li, Gang Wang, Pengfei Yu, Guoxiao Liu, Hua Wang, Huijie Kang, Jiayu Liu, Yu Zhang, Jian-Ping Jin, Kaichun Wu, Jie Liang. Increased expression of calponin 2 is a positive prognostic factor in pancreatic ductal adenocarcinoma. Oncotarget 2017; 8(34) doi: 10.18632/oncotarget.17701
|
| 115 |
R Mezencev, L V Matyunina, G T Wagner, J F McDonald. Acquired resistance of pancreatic cancer cells to cisplatin is multifactorial with cell context-dependent involvement of resistance genes. Cancer Gene Therapy 2016; 23(12) doi: 10.1038/cgt.2016.71
|
| 116 |
Amy Makler, Ramaswamy Narayanan, Waseem Asghar. An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma. Biosensors 2022; 12(10) doi: 10.3390/bios12100831
|